Aerovate Therapeutics
AVTE
#9167
Rank
A$0.11 B
Marketcap
$4.06
Share price
-1.17%
Change (1 day)
-84.00%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.86 Million

According to Aerovate Therapeutics's latest financial reports the company's total debt is A$0.86 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Aerovate Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$1.6 M102.31%
2021-12-31A$0.79 M
2020-12-31N/A-100%
2019-12-31A$3.57 M